-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoMed Therapeutics Has Entered Into A Business & Research Collaboration Agreement With Mumbai-Based SunAct Cancer Institute Private

Benzinga·01/06/2025 12:05:05
Listen to the news

The collaboration forms a collaborative effort between CytoMed and SunAct to explore and investigate the safety, tolerability, potency, and efficacy of CytoMed's proprietary allogeneic gamma delta T cells for the treatment of various cancers (including solid tumors) in human subjects through clinical research, including a Phase 2 investigator-initiated trial in India. 

CytoMed and SunAct will be the joint sponsors of the Clinical Trial.